Title: Promotion of natural tooth repair by small molecule GSK3 antagonists.
Journal: Scientific reports 20170101
Title: Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study.
Journal: Journal of Alzheimer's disease : JAD 20130101
Title: Evidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusib.
Journal: The Journal of biological chemistry 20120106
Title: Exploring the binding sites of glycogen synthase kinase 3. Identification and characterization of allosteric modulation cavities.
Journal: Journal of medicinal chemistry 20111222
Title: Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.
Journal: Journal of medicinal chemistry 20110623
Title: Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment.
Journal: International journal of Alzheimer's disease 20110101
Title: A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo.
Journal: Neurobiology of disease 20090901
Title: NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20070523
Title: Domínguez JM, et al. Evidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusib. J Biol Chem, 2012, 287(2), 893-90
Title: Luna-Medina R, et al. NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders. J Neurosci, 2007, 27(21), 5766-5776.
